The results showed that different AJCC stages were associated with varying levels of GTSE1 expression in nine different tumors (p < 0.05; Figure 1B), including adrenocortical carcinoma (ACC), breast invasive carcinoma (BRCA), kidney chromophobe (KICH), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), liver hepatocellular carcinoma (LIHC), LUAD, rectum adenocarcinoma (READ), and thyroid carcinoma (THCA). The gene discussed is GTSE1; the disease is reading.